sr 48692 has been researched along with n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin) | Trials (n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin) | Recent Studies (post-2010) (n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 9 | 0 | 7 |
| Protein | Taxonomy | sr 48692 (IC50) | n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin (IC50) |
|---|---|---|---|
| Sucrase-isomaltase | Mus musculus (house mouse) | 0.5 | |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 3.5 | |
| Ceramide glucosyltransferase | Mus musculus (house mouse) | 0.2 | |
| Lysosomal acid glucosylceramidase | Homo sapiens (human) | 0.15 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.09 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.4 | |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | 0.55 | |
| Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
| Lysosomal alpha-glucosidase | Mus musculus (house mouse) | 4 | |
| Ceramide glucosyltransferase | Homo sapiens (human) | 0.1325 | |
| Non-lysosomal glucosylceramidase | Homo sapiens (human) | 0.0015 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D | 1 |
1 review(s) available for sr 48692 and n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin
| Article | Year |
|---|---|
The many faces of the adamantyl group in drug design.
Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility | 2011 |